Healthcare provider profile · identity verified

Mukta Bansal, M.D.

Internal Medicine · VOORHEES, NJ · NPI 1992938765

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	421	56
Amlodipine Besylate	Amlodipine Besylate	210	31
Gabapentin	Gabapentin	208	27
Lisinopril	Lisinopril	191	24
Furosemide	Furosemide	160	26
Pantoprazole Sodium	Pantoprazole Sodium	151	31
Famotidine	Famotidine	147	26
Eliquis	Apixaban	127	20
Carvedilol	Carvedilol	126	18
Clopidogrel	Clopidogrel Bisulfate	125	14
Losartan Potassium	Losartan Potassium	125	18
Tamsulosin Hcl	Tamsulosin Hcl	125	17
Levothyroxine Sodium	Levothyroxine Sodium	123	18
Metformin Hcl Er	Metformin Hcl	116	12
Escitalopram Oxalate	Escitalopram Oxalate	105	17
Rosuvastatin Calcium	Rosuvastatin Calcium	105	14
Duloxetine Hcl	Duloxetine Hcl	96	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	95	13
Metformin Hcl	Metformin Hcl	95	13
Pravastatin Sodium	Pravastatin Sodium	93	13
Metoprolol Succinate	Metoprolol Succinate	92	15
Buspirone Hcl	Buspirone Hcl	77	13
Omeprazole	Omeprazole	77	suppressed
Trazodone Hcl	Trazodone Hcl	76	13
Hydralazine Hcl	Hydralazine Hcl	66	11
Lorazepam	Lorazepam	63	14
Metoprolol Tartrate	Metoprolol Tartrate	62	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	suppressed
Potassium Chloride	Potassium Chloride	59	suppressed
Risperidone	Risperidone	57	12
Mirtazapine	Mirtazapine	56	suppressed
Latanoprost	Latanoprost	54	13
Torsemide	Torsemide	54	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	52	suppressed
Ozempic	Semaglutide	50	suppressed
Sertraline Hcl	Sertraline Hcl	49	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	11
Xarelto	Rivaroxaban	49	suppressed
Clonazepam	Clonazepam	48	suppressed
Glipizide Er	Glipizide	48	suppressed
Citalopram Hbr	Citalopram Hydrobromide	46	suppressed
Tizanidine Hcl	Tizanidine Hcl	46	suppressed
Alprazolam	Alprazolam	43	suppressed
Carvedilol Er	Carvedilol Phosphate	42	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	41	24
Jantoven	Warfarin Sodium	41	suppressed
Levetiracetam	Levetiracetam	41	suppressed
Lamotrigine	Lamotrigine	40	suppressed
Tramadol Hcl	Tramadol Hcl	40	11
Alendronate Sodium	Alendronate Sodium	39	suppressed
Trulicity	Dulaglutide	39	suppressed
Novofine 32	Pen Needle, Diabetic	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	23
Prednisone	Prednisone	35	12
Amiodarone Hcl	Amiodarone Hcl	34	suppressed
Aripiprazole	Aripiprazole	34	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	34	suppressed
Finasteride	Finasteride	33	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Dapagliflozin	Dapagliflozin Propanediol	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	31	suppressed
Entresto	Sacubitril/Valsartan	30	suppressed
Risperidone Odt	Risperidone	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Allopurinol	Allopurinol	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Clonidine	Clonidine	24	suppressed
Prednisolone Acetate	Prednisolone Acetate	24	suppressed
Buprenorphine	Buprenorphine	23	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Simvastatin	Simvastatin	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	19
Ezetimibe	Ezetimibe	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Alogliptin	Alogliptin Benzoate	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Belbuca	Buprenorphine Hcl	20	suppressed
Bumetanide	Bumetanide	20	suppressed
Calcitriol	Calcitriol	19	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	14
Tetrabenazine	Tetrabenazine	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	suppressed
Donepezil Hcl Odt	Donepezil Hcl	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Atenolol	Atenolol	15	suppressed
Clomipramine Hcl	Clomipramine Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	12
Apidra Solostar	Insulin Glulisine	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Galantamine Er	Galantamine Hbr	14	suppressed
Insulin Aspart Prot Mix 70-30	Insulin Aspart Prot/Insuln Asp	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Emgality Syringe	Galcanezumab-Gnlm	13	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	13	suppressed
Linzess	Linaclotide	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Paliperidone Er	Paliperidone	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Baclofen	Baclofen	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Modafinil	Modafinil	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Glipizide	Glipizide	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error